全球立體定位手術設備市場規模（按產品類型、應用、區域範圍和預測）

立體定位手術設備的市場規模及預測

立體定位手術設備市場規模在 2024 年價值 191.5 億美元，預計到 2032 年將達到 277.3 億美元，2026 年至 2032 年的複合年成長率為 4.74%。

• 立體定位手術設備是一種現代醫療設備，可在手術過程中實現精準定位，特別適用於治療腦部疾病、腫瘤和某些神經系統疾病。這些技術利用核磁共振成像 (MRI)、 電腦斷層掃描和 X 光等影像技術，提供3D座標系，使外科醫生能夠精確定位和操作腦部特定區域及其他解剖結構。立體定位手術的應用包括立體定位放射放射線手術、切片檢查和深部腦部刺激電極植入，所有這些手術都提供了微創選擇，可以縮短患者康復時間並改善手術效果。
• 由於影像技術、機器人系統和人工智慧的進步，立體定位手術的潛力令人樂觀。這些進步將提高手術的準確性和有效性，並使更具挑戰性的手術更加安全。
• 神經系統疾病盛行率的上升和人口老化預計將推動對這些設備的需求。與遠端醫療和遠距手術功能的整合有望擴大立體定位治療的覆蓋範圍，使醫療資源匱乏的地區更容易獲得專科治療。

立體定位手術設備的全球市場動態

影響全球立體定位手術設備市場的關鍵市場動態是：

關鍵市場促進因素

• 神經系統疾病盛行率不斷上升：神經系統疾病盛行率不斷上升，推動了立體定位手術設備市場的發展，因為人們對精準診斷和治療方案選擇的需求日益成長。根據世界衛生組織 (WHO) 報告，神經系統疾病是全球傷殘調整生命年 (DALY) 減少的主要原因，也是第二大死因。根據《2019 年全球疾病負擔研究》，這些疾病在全球造成了 2.8 億 DALY。日益加重的疾病負擔需要更精準、恢復時間更短的新型手術方案，推動了對先進立體定位手術技術的需求。
• 微創手術的日益普及：微創手術的日益普及推動了對立體定位設備的需求，該設備具有許多優勢，例如恢復時間更短、併發症率更低。根據美國整形外科醫師協會的數據，2000年至2020年間，微創美容手術成長了174%。 《神經外科雜誌》的一項研究顯示，腦腫瘤手術中微創手術的使用率從2010年的2%上升到2019年的12%。這一發展標誌著外科手術技術朝著更精準、創傷更小的方向發展，從而增加了對用於輔助此類治療的先進立體定位技術的需求。
• 成像技術的進步：影像技術的進步顯著提高了立體定位手術的準確性和有效性，從而推動了立體定位手術器械市場的成長。經濟合作暨發展組織(OECD) 報告稱，OECD 國家每百萬人口擁有的核磁共振造影系統數量從 2013 年的 15.5 台增加到 2019 年的 17.4 台，而同期 CT 掃描儀數量則從 24.1 台增加到 27.8 台。這些影像技術的進步為外科醫生提供了更精確的解剖訊息，從而可以進行更有效的干涉並改善患者的預後。隨著影像技術的進步，利用這些突破的先進立體定位器的需求可能會上升。

主要挑戰

• 病患安全問題：儘管立體定位手術有許多優勢，但其準確性可能會受到病患移動和解剖差異等因素的影響。此類安全問題導致外科醫生猶豫不決。解決這些問題將推動市場創新，鼓勵開發更複雜的成像技術和即時監控系統，從而提高準確性和患者安全性。
• 熟練專業人員短缺：對能夠理解並操作立體定位手術最新技術的熟練人員的需求日益成長。缺乏訓練有素的員工可能會阻礙該行業的擴張。這一困境促使人們投資於教育計畫和培訓項目，最終將培養出更多稱職的員工，並使更多醫療機構能夠有效地運用這些新的手術技術。
• 技術淘汰：快速的技術進步可能導致現有的立體定位設備過時，這給那些在這些系統上投入大量資金的醫療機構帶來了淘汰的擔憂。儘管這充滿挑戰，但它激勵製造商繼續研發結合最新趨勢的下一代技術，以不斷提升立體定位手術的功能和療效。

主要趨勢：

• 機器人輔助手術的應用日益廣泛：立體定位手術中機器人器械的使用日益普及，提高了手術的精確度和控制力。機器人技術可以改善手術效果並縮短恢復時間。隨著醫院尋求採用創新技術來保持市場競爭力、改善患者照護並取得更好療效，最終吸引更多患者，這一趨勢正在推動市場擴張。
• 個人化醫療方法：個人化醫療運動正在影響立體定位手術設備市場。治療方法。隨著越來越多的醫療保健專業人員採用此策略，它將推動對能夠適應個人化治療方案的先進立體定位手術設備的需求，從而刺激技術創新並拓展市場前景。
• 醫療基礎設施投資不斷增加：許多國家正在增加醫療基礎設施投資，以提高外科手術能力，並提供新醫療技術的取得途徑。隨著醫院和診所尋求設施現代化並擴展服務範圍，這一趨勢正在推動立體定位手術技術的使用。不斷增加的投資正在刺激對先進手術設備的需求，從而推動整體市場成長。

目錄

第1章：全球立體定位手術設備市場簡介

• 市場概覽
• 研究範圍
• 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源列表

第4章立體定位手術設備全球市場展望

• 概述
• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 波特五力模型
• 價值鏈分析

第5章全球立體定位手術設備市場（依產品類型）

• 概述
• 伽瑪刀
• 直線加速器（linac）
• 質子束
• 電腦刀

第6章立體定位手術設備全球市場（按應用）

• 概述
• 動靜脈畸形治療
• 腦腫瘤治療
• 癲癇治療
• 帕金森氏症
• 三叉神經痛

7. 全球立體定位手術設備市場（按地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 世界其他地區
  • 拉丁美洲
  • 中東和非洲

第8章全球立體定位手術設備市場的競爭格局

• 概述
• 各公司市場排名
• 主要發展策略

第9章 公司簡介

• Ion Beam Applications SA
• Mevion Medical Systems
• Varian Medical Systems
• Monteris Medical
• Elekta AB
• Micromar
• Accuracy Incorporated
• Inomed
• Alliance Oncology
• Medical AG

第10章 附錄

• 相關調查

Stereotactic Surgery Devices Market Size and Forecast

Stereotactic Surgery Devices Market size was valued at USD 19.15 Billion in 2024 and is projected to reach USD 27.73 Billion by 2032, growing at a CAGR of 4.74% from 2026 to 2032.

• Stereotactic surgery devices are modern medical instruments that allow for accurate targeting during surgical procedures, particularly in the treatment of brain diseases, tumors, and certain neurological conditions. These technologies use imaging techniques like MRI, CT scans, and X-rays to provide a three-dimensional coordinate system, allowing surgeons to precisely pinpoint and operate on specific parts of the brain or other anatomical structures. Stereotactic surgery applications include stereotactic radiosurgery, biopsy treatments, and deep brain stimulation electrode implantation, all of which offer minimally invasive choices that reduce patient recovery time and enhance surgical outcomes.
• The potential of stereotactic surgery equipment seems optimistic, thanks to advances in imaging technology, robotic systems, and artificial intelligence. As these technologies advance, they are projected to improve the precision and efficacy of surgical treatments, enabling more difficult procedures to be performed safely.
• The increasing prevalence of neurological disorders, as well as the aging population, are expected to drive up demand for these devices. Integration with telemedicine and remote surgery capabilities may potentially broaden the scope of stereotactic treatments, making specialized care more accessible in underprivileged areas.

Global Stereotactic Surgery Devices Market Dynamics

The key market dynamics that are shaping the global stereotactic surgery devices market include:

Key Market Drivers:

• Increasing Prevalence of Neurological Disorders: The increased prevalence of neurological disorders is driving the stereotactic surgery devices market, as there is a greater need for precise diagnosis and treatment choices. The World Health Organization (WHO) reports that neurological illnesses are the largest cause of disability-adjusted life years (DALYs) and the second highest cause of mortality worldwide. According to the Global Burden of Disease Study 2019, these illnesses account for 280 million DALYs worldwide. This growing burden needs new surgical procedures that provide more accuracy and shorter recovery times, driving demand for sophisticated stereotactic surgery technologies.
• Growing Adoption of Minimally Invasive Surgical Procedures: The increased use of less invasive surgical procedures is driving up demand for stereotactic surgery instruments, which provide several benefits such as shorter recovery times and lower complication rates. According to the American Society of Plastic Surgeons, minimally invasive cosmetic operations increased by 174% between 2000 and 2020. Research in the Journal of Neurosurgery found that the usage of minimally invasive procedures for brain tumor surgery grew from 2% in 2010 to 12% in 2019. This development indicates a shift toward more accurate and less traumatic surgical methods, which is increasing the demand for advanced stereotactic technologies that aid such treatments.
• Advancements in Imaging Technologies: Imaging technology advancements are considerably improving the precision and efficacy of stereotactic procedures, resulting in market growth for stereotactic surgical instruments. The Organization for Economic Cooperation and Development (OECD) reported an increase in MRI units per million population in OECD countries from 15.5 in 2013 to 17.4 in 2019, while CT scanners increased from 24.1 to 27.8 during the same period. These advancements in imaging technologies allow surgeons to gain more precise anatomical information, resulting in more effective interventions and better patient outcomes. As imaging technology advances, there will be an increased demand for advanced stereotactic devices that take advantage of these breakthroughs.

Key Challenges:

• Patient Safety Concerns: Despite their benefits, the precision of stereotactic procedures might be hampered by factors such as patient movement or anatomical differences. These safety issues can cause hesitation among surgeons. Resolving these problems encourages the development of more complex imaging technologies and real-time monitoring systems that increase accuracy and patient safety, promoting market innovation.
• Shortage of Skilled Professionals: There is an increasing demand for skilled individuals who can operate and understand the latest technologies used in stereotactic surgery. The shortage of trained staff has the potential to hinder industry expansion. This difficulty promotes investment in educational initiatives and training programs, which will eventually assist in producing a more competent staff and ensure that more facilities can efficiently use these new surgical techniques.
• Technological Obsolescence: Rapid technological improvements might render existing stereotactic devices obsolete, raising worries about obsolescence for medical facilities that make significant investments in these systems. While this is a difficulty, it motivates manufacturers to continue researching and developing next-generation technologies that combine the most recent advances, hence continuously improving the capabilities and effectiveness of stereotactic procedures.

Key Trends:

• Increased Use of Robotic-Assisted Surgery: The use of robotic devices in stereotactic surgery is gaining popularity, improving precision and control during treatments. Robotics improves surgery results and shortens recuperation periods. This trend is propelling market expansion as hospitals attempt to implement innovative technologies in order to remain competitive, improve patient care, and achieve better results, ultimately attracting more patients.
• Personalized Medicine Approach: The personalized medicine movement is having an impact on the market for stereotactic surgery devices. Tailoring therapy to unique patient features can result in improved surgical outcomes. As more healthcare practitioners embrace this strategy, there is a greater demand for advanced stereotactic devices capable of accommodating tailored treatment programs, which drives innovation and expands market prospects.
• Increased Investment in Healthcare Infrastructure: Many countries are investing in healthcare infrastructure to improve surgical capabilities and provide access to new medical technologies. This trend encourages the use of stereotactic surgery technologies as hospitals and clinics look to modernize their facilities and expand their service offerings. Increased investment drives up demand for sophisticated surgical devices, resulting in total market growth.

Global Stereotactic Surgery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global stereotactic surgery devices market:

North America:

• The North American region currently dominates the stereotactic surgery equipment market, thanks to its advanced healthcare infrastructure, major research institutes, and large patient population suffering from neurological disorders. The high prevalence of neurological events, such as strokes, contributes greatly to this demand; the Centers for Disease Control and Prevention (CDC) says that roughly 795,000 strokes occur in the United States each year, many of which could benefit from stereotactic therapies. The National Brain Tumor Society believes that approximately 700,000 Americans have a primary brain tumor, with a projected 89,000 new diagnoses in 2024. The growing reliance on stereotactic radiosurgery for brain malignancies drives the expansion of this market sector.
• The North American stereotactic surgery devices market is expected to maintain its dominant position. The increase in the number of neurosurgeons from 3,500 in 2012 to over 5,700 in 2024 represents a developing field that will increasingly rely on stereotactic technology. The increase in the number of neurosurgeons from 3,500 in 2012 to over 5,700 in 2024 represents a developing field that will increasingly rely on stereotactic technology. The US Food and Drug Administration (FDA) has fostered innovation by approving new devices, such as 7D Surgical's MvIGS system in 2021, demonstrating continued progress in this field. As the population ages, with forecasts predicting that by 2030, one in every five Americans will be 65 or older, the demand for effective neurological treatment alternatives is likely to increase, propelling market expansion even further.

Asia Pacific:

• The Asia Pacific region is rapidly emerging as the fastest-growing market for stereotactic surgery devices, owing to a combination of factors such as the rising prevalence of neurological diseases, rising disposable income, increased awareness of advanced treatment options, and significant government initiatives aimed at improving healthcare infrastructure. The World Health Organization (WHO) highlights neurological illnesses as a prominent cause of disability and mortality in this region, with the Global Burden of Disease Study 2019 estimating 150 million disability-adjusted life years (DALYs) in Southeast Asia. This urgent need for efficient treatment solutions is driving up demand for stereotactic surgery as an advanced intervention for illnesses such as brain tumors, which are becoming more common.
• The Asia Pacific stereotactic surgery devices market is poised for significant expansion. This expansion is further aided by government programs such as China's "Healthy China 2030" plan, which intends to increase healthcare expenditures and technology adoption, and India's National Health Policy 2017, which aims to raise public health expenditure.
• Rapid urbanization and rising disposable incomes in countries such as China and India are also driving market growth, as more people have access to innovative medical treatments. As knowledge of these new solutions rises, along with continued improvements in healthcare infrastructure, the Asia Pacific stereotactic surgical devices market is likely to continue its rapid expansion, potentially outpacing other global markets.

Global Stereotactic Surgery Devices Market: Segmentation Analysis

The Global Stereotactic Surgery Devices Market is Segmented on the basis of Product Type, Application, And Geography.

Stereotactic Surgery Devices Market, By Product Type

• Gamma Knife
• Line Accelerator (LINAC) Machines
• Proton Beam
• CyberKnife

Based on Product Type, the market is bifurcated into Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, and CyberKnife. Gamma Knife technology is currently dominant due to its proven effectiveness in treating brain tumors and other neurological problems. The Gamma Knife, known for its precision in delivering large doses of radiation while limiting damage to surrounding healthy tissues, has become a preferred choice for neurosurgeons, contributing to its widespread use. CyberKnife is emerging as the fastest-growing segment, thanks to its adaptability and capacity to treat tumors in a variety of sites across the body. Unlike older methods, CyberKnife employs real-time imaging and robotic technology, making non-invasive treatments more appealing to patients and healthcare providers. This expansion is aided by advances in robotic technology and increased knowledge of minimally invasive treatment choices.

Stereotactic Surgery Devices Market, By Application

• Arteriovenous Malformations Treatment
• Brain Tumor Treatment
• Epilepsy
• Parkinson's Disease

Based on Application, the market is segmented into Arteriovenous Malformations Treatment, Brain Tumor Treatment, Epilepsy, and Parkinson's Disease. The Brain Tumor sector is currently a leading due to the high occurrence of primary and metastatic brain tumors, which require precision treatment options such as stereotactic radiosurgery. This segment benefits from modern technology that improve treatment outcomes while minimizing dangers. The Epilepsy segment is expanding at a rapid pace, owing to increased understanding and adoption of stereotactic approaches for treating intractable seizures. As more patients look for alternatives to medication, the need for less invasive techniques such stereotactic surgery to target seizure foci is fast increasing, driving growth in this market.

Stereotactic Surgery Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Stereotactic Surgery Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The North American region currently dominates the market for stereotactic surgery devices due to its advanced healthcare infrastructure, strong research base, and large patient population. However, the Asia-Pacific region is witnessing the fastest rise, owing to an increase in the frequency of neurological disorders, rising disposable income, and more awareness of improved treatment alternatives. This region is also benefiting from positive government initiatives and investments in healthcare infrastructure.

Key Players

The "Global Stereotactic Surgery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Ion Beam Applications S.A., Mevion Medical Systems, Varian Medical Systems, Monteris Medical, Elekta AB, Micromar, Accuracy Incorporated, Inomed, Alliance Oncology, and Medical AG. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Stereotactic Surgery Devices Market Recent Developments
• In February 2024, Elekta enhanced its Asian market position with the acquisition of Premier Business Inter (PBI), a Thai distributor.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL STEREOTACTIC SURGERY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Gamma knife
• 5.3 Line accelerator (LINAC) machines
• 5.4 Proton beam
• 5.5 CyberKnife

6 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Arteriovenous malformations treatment
• 6.3 Brain tumor treatment
• 6.4 Epilepsy
• 6.5 Parkinson's disease
• 6.6 Trigeminal Neuralgia

7 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL STEREOTACTIC SURGERY DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Ion Beam Applications S.A.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Mevion Medical Systems
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Varian Medical Systems
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Monteris Medical
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Elekta AB
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Micromar
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Accuracy Incorporated
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Inomed
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Alliance Oncology
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Medical AG
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research